CL2011000208A1 - Combinacion coccidicida que comprende toltrazuril y trimetoprim; uso de dicha combinacion para tratar coccidiosis en aves o mamiferos. - Google Patents

Combinacion coccidicida que comprende toltrazuril y trimetoprim; uso de dicha combinacion para tratar coccidiosis en aves o mamiferos.

Info

Publication number
CL2011000208A1
CL2011000208A1 CL2011000208A CL2011000208A CL2011000208A1 CL 2011000208 A1 CL2011000208 A1 CL 2011000208A1 CL 2011000208 A CL2011000208 A CL 2011000208A CL 2011000208 A CL2011000208 A CL 2011000208A CL 2011000208 A1 CL2011000208 A1 CL 2011000208A1
Authority
CL
Chile
Prior art keywords
combination
toltrazuril
coccidicidal
birds
mammals
Prior art date
Application number
CL2011000208A
Other languages
English (en)
Inventor
Bernardo Lozano-Dubernard
Luis Ocampo-Camperos
Hector Salvador Sumano-Lopez
Ernesto Soto-Priante
David Sarfati-Mizrahi
Original Assignee
Laboratorio Avi Mex S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Avi Mex S A De C V filed Critical Laboratorio Avi Mex S A De C V
Publication of CL2011000208A1 publication Critical patent/CL2011000208A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNA COMPOSICIÓN COCCIDICIDA DEL TIPO QUE COMPRENDE UNA COMBINACIÓN DE TOLTRAZURIL: 1-METIL-3-[3- METIL-4-[4-(TRIFLUOROMETIL)TIO) FENOXIL]FENIL]-1 ,3,5-TRIAZÍNA(1H,3H, 5H)-2,4,6-TRIONA; Y TRIMETOPRIM: 5-[(3,4,5- TRIMETOXIFENIL)METIL]PIRIMIDIN-2,4-DIAMINA; Y, UN VEHÍCULO FARMACÉUTICAMENTE ACEPTABLE QUE TIENE UN PH BÁSICO Y ES UNA SUSPENSIÓN QUE COMPRENDE DE 20 A 30 MG DE TOLTRAZURÍL POR CADA ML DE SUSPENSIÓN; Y DE 20 A 150 MG DE TRIMETOPRIM POR CADA ML DE SUSPENSIÓN. EL USO DE DICHA COMPOSICIÓN EN LA PREPARACIÓN DE UN MEDICAMENTO ÚTIL EN EL TRATAMIENTO DE COCCIDIOSIS EN AVES O MAMÍFEROS.
CL2011000208A 2008-07-31 2011-01-31 Combinacion coccidicida que comprende toltrazuril y trimetoprim; uso de dicha combinacion para tratar coccidiosis en aves o mamiferos. CL2011000208A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2008009818A MX2008009818A (es) 2008-07-31 2008-07-31 Combinacion coccidicida para uso veterinario.

Publications (1)

Publication Number Publication Date
CL2011000208A1 true CL2011000208A1 (es) 2011-05-06

Family

ID=41610000

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000208A CL2011000208A1 (es) 2008-07-31 2011-01-31 Combinacion coccidicida que comprende toltrazuril y trimetoprim; uso de dicha combinacion para tratar coccidiosis en aves o mamiferos.

Country Status (13)

Country Link
EP (1) EP2319515B1 (es)
AR (1) AR072889A1 (es)
BR (1) BRPI0911719A8 (es)
CL (1) CL2011000208A1 (es)
CO (1) CO6341549A2 (es)
DK (1) DK2319515T3 (es)
DO (1) DOP2011000030A (es)
ES (1) ES2475266T3 (es)
MX (1) MX2008009818A (es)
PE (1) PE20110401A1 (es)
PL (1) PL2319515T3 (es)
PT (1) PT2319515E (es)
WO (1) WO2010013129A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552477A (zh) * 2010-12-09 2012-07-11 天津瑞贝特科技发展有限公司 治疗鸡球虫病的中药组合物及其制备方法
ITTO20111219A1 (it) 2011-12-28 2013-06-29 Beta Renewables Spa Procedimento migliorato di pre-impregnazione per la conversione di biomassa
MX2017014439A (es) * 2015-05-11 2018-03-02 Grupo Ind Pecuario S A De C V Composicion para el tratamiento de parasitosis por gregarinas en camarones.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454859B (sv) 1983-11-16 1988-06-06 Stig Olofsson Platta
DE4030042A1 (de) 1990-05-17 1991-11-21 Bayer Ag Verwendung von substituierten 1,2,4-triazindionen
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
WO1998043644A1 (en) * 1997-03-31 1998-10-08 David Granstrom Formulations and methods to treat and prevent equine protozoal myeloencephalitis
DE19958388A1 (de) 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten

Also Published As

Publication number Publication date
PT2319515E (pt) 2014-05-27
CO6341549A2 (es) 2011-11-21
EP2319515A4 (en) 2011-12-21
EP2319515B1 (en) 2014-05-07
MX2008009818A (es) 2010-02-01
PL2319515T3 (pl) 2014-10-31
BRPI0911719A2 (pt) 2015-10-06
DOP2011000030A (es) 2011-04-15
WO2010013129A1 (es) 2010-02-04
AR072889A1 (es) 2010-09-29
DK2319515T3 (da) 2014-06-30
BRPI0911719A8 (pt) 2018-03-06
PE20110401A1 (es) 2011-07-24
EP2319515A1 (en) 2011-05-11
ES2475266T3 (es) 2014-07-10

Similar Documents

Publication Publication Date Title
JOP20200160A1 (ar) محاليل معلقة مائية للمركبات المسمى تي ام سي 278
Dua et al. Pharmacological significance of synthetic heterocycles scaffold: a review
EA200900799A1 (ru) Гетероарилгетероарильные соединения как ингибиторы cdk, предназначенные для лечения рака, воспаления и борьбы с вирусными инфекциями
PE20110235A1 (es) Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
ATE474835T1 (de) Als inhibitoren von proteinkinasen geeignete aminopyrimidine
PE20051171A1 (es) Inhibidores de proteina quinasas con estructura de 3-quinolincarbonitrilo
EA200970273A1 (ru) Применение 2-6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2н-пиримидин-1-илметил-4-фторбензонитрила
EA200802203A1 (ru) Дикетопиперазиновые и пиперидиновые производные в качестве противовирусных агентов
CL2008003595A1 (es) Compuestos heterociclicos nitrogenados, antagonistas del receptor de taquiquinina; agente farmaceutico que comprende el compuesto; y uso en la profilaxis o el tratamiento de una enfermedad del tracto urinario inferior, una enfermedad gastrointestinal o una enfermedad del sistema nervioso central.
EA200800726A1 (ru) Введение ингибиторов дипептидилпептидазы
CL2008001230A1 (es) Compuestos derivados de pirrol (2.3-d)pirimidina. purin-6-ilo o pirazol(3,4-d)pirimldina, inhibidores de quinasa p70 s6; composición farmaceutica; y uso para la preparación de medicamentos utiles en el tratamiento de adenocarcinomas del colon e inhibición de angiogénesis.
EA200800441A1 (ru) Замещенные бензимидазолы в качестве ингибиторов киназ
TW200628452A (en) Substituted 2-anilinopyrimidines as cell-cycle-kinase or receptor-tyrosine-kinase inhibitors, their production and use as pharmaceutical agents
CR9984A (es) Método de inhibición de cinasa de tirosina cinasa 3 similar a fms
SI3009428T1 (en) DIAMINO HETEROCYCLIC CARBOSAMIDE COMPOUNDS
CL2007001733A1 (es) Compuestos derivados de imidazol condensado con heterociclos nitrogenados; composicion farmaceutica; y uso para tratar o prevenir un trastorno asociado con el deterioro cognitivo, la enfermedad de alzheimer, demencia senil y demencia asociada con enfermedad de parkinson entre otras.
MX2009010886A (es) Derivados de pirimidina como inhibidores de fosfatidilinositol-3-c inasa.
ATE508126T1 (de) Als kinaseinhibitoren geeignete aminopyrimidine
NO20085331L (no) Pyrazolo[1,5-A]pyrimidiner som CDK-inhibitorer
ATE457311T1 (de) Als inhibitoren von proteinkinasen geeignete aminopyridine und aminopyrimidine
CL2008002880A1 (es) (s)-2-amino-3-(4-(2-amino-6-((r-1-(4-cloro-2-(3-metil-1h-pirazol-1-il)fenil)-2,2,2-trifluoroetoxi)pirimidin-4-il)fenil)propanoato de etilo cristalino, sal hipurato y succionato del mismo; metodos de preparacion; forma de dosificacion farmaceutica; y uso para tratar sindrome carcinoide y trastorno gastrointestinal.
GT200900147A (es) Derivados de pirimidina y los métodos para su uso
PE20090895A1 (es) Derivados de triazol como inhibidores de la jak quinasa
CL2011000195A1 (es) Compuestos derivados de 5-alquinil-pirimidina, inhibidores de quinasas; composiciones farmaceuticas que comprenden a los compuestos; y uso de los compuestos en la preparacion de medicamentos para el tratamiento del cancer.
NZ580671A (en) Pyrimidine derivatives